首页> 外文期刊>Frontiers in Immunology >Mycobacterium tuberculosis DosR Regulon Gene Rv2004c Encodes a Novel Antigen with Pro-inflammatory Functions and Potential Diagnostic Application for Detection of Latent Tuberculosis
【24h】

Mycobacterium tuberculosis DosR Regulon Gene Rv2004c Encodes a Novel Antigen with Pro-inflammatory Functions and Potential Diagnostic Application for Detection of Latent Tuberculosis

机译:结核分枝杆菌 DosR Regulon基因 Rv2004c 编码具有促炎功能的新型抗原,在潜在潜伏性结核病的诊断中具有潜在的诊断应用

获取原文
           

摘要

Approximately 1.7 billion people in the world harbor latent Mycobacterium tuberculosis (Mtb) with a substantial risk of progression to clinical outcome. Containment of these seed beds of Mtb is essential to eliminate tuberculosis completely in high burden settings such as India. Hence, there is an urgent need for the identification of new serological markers for detection or vaccine candidates to prevent latent tuberculosis infection (LTBI). DosR regulon antigens of Mtb might serve as attractive targets for LTBI diagnosis or vaccine development as they are specifically expressed and are upregulated during latent phase. In this study, we investigated the role of Rv2004c , a member of DosR regulon (exclusive to Mtb complex), in host–pathogen interaction and its immunogenic potential in LTBI, active TB, and healthy control cohorts. Rv2004c elicited strong antibody response in individuals with LTBI compared to active TB patients and healthy cohorts. Recombinant Rv2004c induced pro-inflammatory cytokine response in human peripheral blood mononuclear cells and THP-1 cells via NF-κB phosphorylation. Interaction of Rv2004c with toll-like receptor (TLR)-2 was confirmed using HEK-Blue hTLR-2 and pull-down assays. Rv2004c enhanced the surface expression of TLR-2 at mRNA and protein levels in THP-1 cells. Our findings revealed that Rv2004c induces strong humoral and cell mediated immune responses. Given these observations, we propose Rv2004c to be a potential diagnostic marker or an attractive vaccine candidate that can be useful against LTBI.
机译:世界上大约有17亿人患有潜伏的结核分枝杆菌(Mtb),具有发展为临床结果的巨大风险。封闭这些Mtb种子床对于在印度等高负荷地区完全消除结核病至关重要。因此,迫切需要鉴定新的用于检测的血清学标志物或候选疫苗,以预防潜伏性结核感染(LTBI)。 Mtb的DosR regulon抗原可作为LTBI诊断或疫苗开发的有吸引力的靶标,因为它们在潜伏期被特异性表达并被上调。在这项研究中,我们调查了DosR regulon成员Rv2004c(Mtb复合物除外)在宿主-病原体相互作用中的作用及其在LTBI,活动性TB和健康对照人群中的免疫原性潜力。与活跃的结核病患者和健康人群相比,Rv2004c在LTBI患者中引起强烈的抗体反应。重组Rv2004c通过NF-κB磷酸化诱导人外周血单核细胞和THP-1细胞的促炎性细胞因子反应。 Rv2004c与收费样受体(TLR)-2的相互作用已通过HEK-Blue hTLR-2和下拉测定法得以证实。 Rv2004c在THP-1细胞中在mRNA和蛋白质水平上增强了TLR-2的表面表达。我们的发现表明,Rv2004c诱导强烈的体液和细胞介导的免疫反应。鉴于这些观察结果,我们建议Rv2004c作为潜在的诊断标志物或有吸引力的疫苗候选物,可用于对抗LTBI。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号